Jennison Associates LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 124.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,709,635 shares of the company’s stock after purchasing an additional 948,017 shares during the quarter. Jennison Associates LLC’s holdings in GE HealthCare Technologies were worth $133,659,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewEdge Advisors LLC lifted its stake in GE HealthCare Technologies by 5.6% in the second quarter. NewEdge Advisors LLC now owns 14,645 shares of the company’s stock valued at $1,141,000 after buying an additional 775 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of GE HealthCare Technologies by 9.5% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 8,150 shares of the company’s stock worth $636,000 after acquiring an additional 710 shares during the period. Quarry LP lifted its position in GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock valued at $46,000 after purchasing an additional 131 shares during the last quarter. Cetera Investment Advisers boosted its stake in GE HealthCare Technologies by 7.7% during the 2nd quarter. Cetera Investment Advisers now owns 73,713 shares of the company’s stock valued at $5,744,000 after purchasing an additional 5,239 shares during the period. Finally, Sanctuary Advisors LLC bought a new position in GE HealthCare Technologies in the 2nd quarter worth about $1,382,000. Institutional investors and hedge funds own 82.06% of the company’s stock.
Wall Street Analysts Forecast Growth
GEHC has been the topic of a number of recent analyst reports. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.
Insider Activity
In other news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.27% of the company’s stock.
GE HealthCare Technologies Stock Down 1.4 %
GEHC opened at $88.30 on Monday. The stock’s fifty day moving average is $82.87 and its 200-day moving average is $85.04. GE HealthCare Technologies Inc. has a one year low of $72.52 and a one year high of $94.55. The company has a market capitalization of $40.34 billion, a PE ratio of 24.26, a P/E/G ratio of 2.92 and a beta of 1.14. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.
GE HealthCare Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- 5 discounted opportunities for dividend growth investors
- 3X-Leveraged ETFs: Amplify Returns With These 3 Top Picks
- What Are Dividend Champions? How to Invest in the Champions
- 3 Underrated Robotics Stocks Poised for Major Growth
- 3 Warren Buffett Stocks to Buy Now
- Reshoring Riches: Investing in Made in America 2.0
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.